Component

Retinal function in abetalipoproteinemia

Retinal function in abetalipoproteinemia. Read linked claims for the population, experiment and limits.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The six-patient abetalipoproteinemia report noted that vitamin A alone had not prevented or arrested the retinal lesion, whereas long-term regimens including vitamin E modified its course.

    Vitamin A → Retinal function in abetalipoproteinemia source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    true
    experimental_model
    Six-patient long-term abetalipoproteinemia case series
    exposure
    Large oral vitamin E doses for 12–18 years alongside low-fat diet and other fat-soluble vitamins; exact dose absent from the abstract.
    limitations
    Uncontrolled co-treatment series; cannot isolate vitamin E effect or demonstrate nutrient synergy. Genetic lipid transport disease differs from simple low intake.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    In this transport disease, vitamin A alone did not substitute for the broader treatment that included vitamin E.
    primary_references
    [e-clin-retina1986] Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia. (1986). https://pubmed.ncbi.nlm.nih.gov/3954973/ DOI: 10.1136/bjo.70.3.166
    tissue_or_cell_type
    Retina
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1453–1464

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Six-patient long-term abetalipoproteinemia case series · source_derived_draft · unverified_draft

    ### e-clin-abetalipo-a-alone The six-patient abetalipoproteinemia report noted that vitamin A alone had not prevented or arrested the retinal lesion, whereas long-term regimens including vitamin E modified its course. Condition category: machinery_impairment nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: In this transport disease, vitamin A alone did not substitute for the broader treatment that included vitamin E. organism: Homo sapiens tissue_or_cell_type: Retina experimental_model: Six-patient long-term abetalipoproteinemia case series limitations: Uncontrolled co-treatment series; cannot isolate vitamin E effect or demonstrate nutrient synergy. Genetic lipid transport disease differs from simple low intake. exposure: Large oral vitamin E doses for 12–18 years alongside low-fat diet and other fat-soluble vitamins; exact dose absent from the abstract. cross_nutrient: true [e-clin-retina1986] Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia. (1986). https://pubmed.ncbi.nlm.nih.gov/3954973/ DOI: 10.1136/bjo.70.3.166
    Complete structured claim and evidence

  2. Despite combined vitamin A and E treatment, 11 of 13 ABL/HBL patients had subnormal mixed cone-rod electroretinogram amplitudes at long-term follow-up.

    Vitamin E → Retinal function in abetalipoproteinemia source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    true
    experimental_model
    Longitudinal treated cohort; 10 abetalipoproteinemia and 3 homozygous hypobetalipoproteinemia patients
    exposure
    Combined oral vitamins A and E; mean 11.7 years follow-up, range 4–20; exact doses unavailable in abstract.
    limitations
    No randomized A-only, E-only or untreated comparator. Residual retinal disease is compatible with partial benefit; it is not proof that supplementation has no effect.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    Combined treatment did not fully prevent retinal abnormalities in every patient.
    primary_references
    [e-clin-retina2001] Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. (2001). https://pubmed.ncbi.nlm.nih.gov/11767031/ DOI: 10.1038/eye.2001.167
    tissue_or_cell_type
    Retina
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1466–1477

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Longitudinal treated cohort; 10 abetalipoproteinemia and 3 homozygous hypobetalipoproteinemia patients · source_derived_draft · unverified_draft

    ### e-clin-abetalipo-residual-retinopathy Despite combined vitamin A and E treatment, 11 of 13 ABL/HBL patients had subnormal mixed cone-rod electroretinogram amplitudes at long-term follow-up. Condition category: machinery_impairment nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Combined treatment did not fully prevent retinal abnormalities in every patient. organism: Homo sapiens tissue_or_cell_type: Retina experimental_model: Longitudinal treated cohort; 10 abetalipoproteinemia and 3 homozygous hypobetalipoproteinemia patients limitations: No randomized A-only, E-only or untreated comparator. Residual retinal disease is compatible with partial benefit; it is not proof that supplementation has no effect. exposure: Combined oral vitamins A and E; mean 11.7 years follow-up, range 4–20; exact doses unavailable in abstract. cross_nutrient: true [e-clin-retina2001] Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. (2001). https://pubmed.ncbi.nlm.nih.gov/11767031/ DOI: 10.1038/eye.2001.167
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards